Clinical Trial Detail

NCT ID NCT02956382
Title Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Georgetown University
Indications

follicular lymphoma

Therapies

Ibrutinib + Venetoclax

Age Groups: adult senior

No variant requirements are available.